Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

17.86
0.0000
Post-market: 17.860.00000.00%19:30 EDT
Volume:2.13M
Turnover:38.05M
Market Cap:56.84B
PE:-56.09
High:17.89
Open:17.85
Low:17.78
Close:17.86
52wk High:19.10
52wk Low:12.99
Shares:3.18B
Float Shares:3.09B
Volume Ratio:0.91
T/O Rate:0.07%
Dividend:0.63
Dividend Rate:3.55%
EPS(TTM):-0.3184
EPS(LYR):-0.3042
ROE:-2.26%
ROA:2.69%
PB:1.19
PE(LYR):-58.70

Loading ...

Analysts Conflicted on These Healthcare Names: Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinger (SDGR)

TIPRANKS
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Yomiuri: Japan Set to Approve Drug That Treats Narcolepsy

Dow Jones
·
Aug 06

Takeda Advances Pediatric Pouchitis Trial, Extending Entyvio’s Long‑Term Growth Story

TIPRANKS
·
Aug 04

Takeda Tracks Real World Safety of Ceprotin (TAK-662) in Rare Clotting Disorder

TIPRANKS
·
Aug 01

NYSE Order Imbalance 114898.0 Shares on Sell Side

THOMSON REUTERS
·
Jul 31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Takeda Pharmaceutical Company (TAK), Align Tech (ALGN) and Conmed (CNMD)

TIPRANKS
·
Jul 31

Takeda Pharmaceutical Fiscal Q1 Core Earnings, Revenue Rise

MT Newswires Live
·
Jul 30

Takeda Pharmaceutical Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $7.655B Beat $7.060B Estimate

Benzinga Earnings
·
Jul 30

Press Release: Takeda Announces Fy2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track

Dow Jones
·
Jul 30

Takeda’s Pediatric GERD Trial Update: What Dexlansoprazole Data Could Mean for TAK Investors

TIPRANKS
·
Jul 30

Takeda Pharmaceutical Co Ltd Expected to Post Earnings of Jpy140.99 a Share - Earnings Preview

Reuters
·
Jul 28

Takeda Expected to Post Lower First-Quarter Net Profit

Dow Jones
·
Jul 28

Takeda’s Elritercept Trial Targets Anemia in Myelofibrosis, Raising Long-Term Upside for TAK

TIPRANKS
·
Jul 25

Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
Jul 24

Earning Preview: Takeda Pharmaceutical Co Ltd Q1 revenue is expected to decrease by 1.08%, and institutional views are bullish

Earnings Agent
·
Jul 24

Immigration: Foreign Lawbreakers May Face Indonesian Prison

Tempo
·
Jul 23

Takeda Pharmaceutical Reports Positive Phase 3 Data for Zasocitinib in Moderate-to-Severe Plaque Psoriasis

MT Newswires Live
·
Jul 17

Takeda’s TAK-226 Anemia Trial Offers New Optionality in Hematology

TIPRANKS
·
Jul 17

Takeda Extends TAK-360 Sleep Trial, Signaling Long-Term Ambitions in Narcolepsy

TIPRANKS
·
Jul 16